Prognostic Impact of Pulmonary Diseases in 952 Patients with Thoracic and/or Abdominal Aortic Aneurysm

Figures

• 

  Figure 1. Kaplan–Meier curve of the probability of development of lung cancer in patients with TAA and/or AAA who did not have lung cancer at the AA diagnosis. AAA = abdominal aortic aneurysm; TAA = thoracic aortic aneurysm; AA = aortic aneurysm.

• 

  Figure 2. Kaplan–Meier curve of the probability of development of acute exacerbation of idiopathic pulmonary fibrosis in patients with TAA and/or AAA who had idiopathic pulmonary fibrosis at AA diagnosis. AA = aortic aneurysm; AAA = abdominal aortic aneurysm; TAA = thoracic aortic aneurysm.

• 

  Figure 3. Kaplan–Meier survival curves by aneurysm type and pulmonary disease. (a) Kaplan–Meier survival curves of all-cause mortality in all patients and those with TAA, AAA, and TAA + AAA. Overall cumulative 5- and 10-year mortality rates were 18.0% and 29.8%, respectively. Respective 5- and 10-year all-cause mortality rates in the TAA, AAA, and TAA + AAA patients were 18.1% and 32.4%, 17.7% and 28.9%, and 19.0% and 27.9%. A log-rank test showed no significant difference between survival curves in the patients with TAA, AAA, and TAA + AAA. Median survival time for all AA patients was 13.6 years (95% CI, 12.5–NR). (b) Kaplan–Meier survival curves of all-cause mortality in patients without pulmonary disease and those with IPF, non-IPF ILD, ILAs, emphysema, LC, and others. Respective 5-year all-cause mortality rates in the patients without pulmonary disease, patients with IPF, non-IPF ILD, ILAs, emphysema, LC, and others were 9.8%, 37.4%, 23.6%, 11.6%, 15.0%, 60.5%, and 11.5%. A pairwise log-rank test showed a significant difference between patients without pulmonary diseases and patients with LC, IPF, and non-IPF ILD (p <0.001, <0.001, and =0.012, respectively). * in the table indicates…